Trial Profile
A phase I trial of zolmitriptan intranasal in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Apr 2012
Price :
$35
*
At a glance
- Drugs Zolmitriptan (Primary) ; Zolmitriptan (Primary)
- Indications Migraine
- Focus Adverse reactions; Pharmacokinetics
- 04 Apr 2012 Status changed from recruiting to completed based on information reported in a Shin Nippon Biomedical Laboratories media release.
- 04 Apr 2012 Results have been reported in a Shin Nippon Biomedical Laboratories media release.
- 19 Aug 2011 New trial record